Cme Group INC 8-K filings

CME Group Inc. has issued a Special Executive Report detailing pricing changes communicated to its clients.

CME Group announced strong financial results for Q2 2026, with record performance in the first half of the year driven by robust trading volumes and market data revenue.

CME Group Inc. is transitioning leadership as CEO Terry Duffy moves to Executive Chairman, with President and CFO Lynne Fitzpatrick succeeding him in March 2027.

CME Group reconvened its 2026 Annual Meeting to vote on proposals, with some failing to pass or achieve quorum, impacting director elections and charter amendments.

CME Group Inc. entered into Amendment No. 11 to its existing 364-day multi-currency revolving credit facility, maintaining a $7 billion capacity.

CME Group Inc. announced record-breaking financial results for the first quarter of 2026, driven by a 14% increase in revenue and a 22% rise in average daily volume across all asset classes.

CME Group Inc. reported record annual revenue, adjusted operating income, adjusted net income, and adjusted earnings per share for 2025, marking its fourth consecutive year of growth.

CME Group Inc. has communicated pricing changes to its clients via Special Executive Report 9676, as disclosed in a recent 8-K filing.

CME Group reported third-quarter 2025 financial results with $1.5 billion in revenue and $908 million in net income, alongside adjusted earnings on par with last year's strong performance.

CME Group Inc. announced that Jack Tobin, its Chief Accounting Officer, will retire in October 2026 after over two decades with the company.

CME Group and its subsidiary, the Board of Trade of the City of Chicago, Inc., secured a unanimous jury verdict in their favor in a long-standing class action lawsuit.

CME Group Inc. reported all-time record revenue of $1.7 billion and average daily volume of 30.2 million contracts for the second quarter of 2025, driven by strong demand across asset classes.

CME Group held its 2025 Annual Meeting of Shareholders on May 8, 2025, with key decisions made on director elections and other proposals.

CME Group has entered into a new $2.25 billion multi-currency revolving credit facility and amended its $7 billion clearing house credit facility to bolster its financial flexibility.

CME Group announces record revenue, adjusted operating income, adjusted net income, and adjusted earnings per share for the first quarter of 2025, fueled by increased demand for risk management tools.

CME Group and S&P Global have reached a definitive agreement to sell their joint venture, OSTTRA, to KKR for an enterprise value of $3.1 billion.

CME Group successfully closed a $750 million public offering of 4.400% notes due in 2030, planning to use the proceeds to redeem existing 2025 notes and for general corporate needs.

CME Group has entered into an underwriting agreement for the issuance and sale of $750 million in notes due in 2030, with a coupon rate of 4.400%.

CME Group announces record-breaking annual financial results for 2024, driven by volume growth across all asset classes.

CME Group Inc. has announced adjustments to its Clearing House collateral fee schedule and client pricing, effective December 11, 2024.

CME Group's board has approved a $2.1 billion annual variable dividend and a $3 billion share repurchase program, demonstrating a commitment to returning capital to shareholders.

CME Group has extended CEO Terry Duffy's contract to December 31, 2026, and appointed Lynne Fitzpatrick as President and CFO, while Suzanne Sprague will take over as COO.

CME Group announced record revenue, adjusted operating income, adjusted net income, and adjusted earnings per share for the third quarter of 2024, driven by strong volume growth across all asset classes.

CME Group achieved record revenue of $1.5 billion and record average daily volume of 26 million contracts in the second quarter of 2024, driven by increased risk management needs across all asset classes.

CME Group has appointed Mike Dennis as Global Head of Fixed Income, effective August 5, 2024, while also announcing his immediate resignation from the company's Board of Directors.

CME Group Inc. successfully held its 2024 Annual Meeting of Shareholders, electing seventeen Equity Directors, ratifying the appointment of Ernst & Young LLP, and approving executive compensation, while also noting that quorums were not achieved for the election of Class B directors.

CME Group has amended its multi-currency credit facility, increasing its borrowing capacity to $7 billion, with a potential expansion to $10 billion, to ensure liquidity in case of clearing member defaults or system delays.

CME Group reported record adjusted net income and earnings per share for the first quarter of 2024, driven by increased trading volumes in U.S. Treasury and commodities markets.

CME Group has amended its Omnibus Stock Plan to include double-trigger change of control vesting provisions, aligning with market practices and shareholder preferences.

CME Group announced record full-year 2023 financial results, driven by strong performance in interest rate products and record average daily volume.